Literature DB >> 7751981

The assessment and prevalence of affective disorders in advanced cancer.

M E Lynch1.   

Abstract

The assessment of depression in patients with advanced cancer presents a difficult clinical challenge. Reported prevalence rates of depression in cancer patients range from 3.7% to 58%. Studies using structured diagnostic interviews and clearly defined diagnostic criteria are presented. The current literature suggests that among hospitalized cancer patients with significant levels of physical impairment at least 25% suffer from clinically important depression. Risk of suicide and recent literature regarding early wish to die are also discussed.

Entities:  

Mesh：

Year:  1995        PMID： 7751981

Source DB:  PubMed          Journal:  J Palliat Care        ISSN： 0825-8597            Impact factor:   2.250


  10 in total

1.  Depressive symptoms and health-related quality of life in breast cancer survivors.

Authors:  Cielito C Reyes-Gibby; Karen O Anderson; Phuong Kanh Morrow; Sanjay Shete; Sohela Hassan
Journal:  J Womens Health (Larchmt)       Date:  2011-11-07       Impact factor: 2.681

2.  Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System.

Authors:  Devon K Check; Marilyn L Kwan; Neetu Chawla; Stacie B Dusetzina; Emily Valice; Isaac J Ergas; Janise M Roh; Tatjana Kolevska; Donald L Rosenstein; Lawrence H Kushi
Journal:  J Pain Symptom Manage       Date:  2018-12-01       Impact factor: 3.612

3.  Assessment and treatment of depression in medically ill children.

Authors:  Eyal Shemesh; Abraham Bartell; Jeffrey H Newcorn
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

4.  Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients.

Authors:  Francisco Gil; Luigi Grassi; Luzia Travado; Michele Tomamichel; Juan Ramón Gonzalez
Journal:  Support Care Cancer       Date:  2005-03-11       Impact factor: 3.603

5.  Using disease-related and demographic variables to form cancer-distress risk groups.

Authors:  R A Schnoll; L L Harlow
Journal:  J Behav Med       Date:  2001-02

Review 6.  Difficulties in diagnosing and treating depression in the terminally ill cancer patient.

Authors:  M Lloyd-Williams
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

7.  Homecare referrals and 12-week outcomes following surgery for cancer.

Authors:  Kathryn H Bowles; Ruth McCorkle; Isaac F Nuamah
Journal:  Oncol Nurs Forum       Date:  2008-05       Impact factor: 2.172

8.  Resting-state brain metabolic fingerprinting clusters (biomarkers) and predictive models for major depression in multiple myeloma patients.

Authors:  Xiaofei Wang; Joshua Eichhorn; Iqbal Haq; Ahmad Baghal
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

9.  Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study.

Authors:  Nauman A Jadoon; Waqar Munir; Mohammad A Shahzad; Zeshan S Choudhry
Journal:  BMC Cancer       Date:  2010-10-29       Impact factor: 4.430

10.  Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention.

Authors:  M Sharpe; V Strong; K Allen; R Rush; P Maguire; A House; A Ramirez; A Cull
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.